Cargando…
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer
Recently, the HOXB13 gene has been shown to be a susceptibility gene for prostate cancer. HOXB13 is overexpressed in breast cancer tissues and HOXB13 expression in combination with low expression of IL17BR is predictive for a tamoxifen response in ER-positive breast cancers. Based on observations, w...
Autores principales: | Akbari, Mohammad R., Kluźniak, Wojciech, Rodin, Rachelle, Li, Song, Wokołorczyk, Dominika, Royer, Robert, Kashyap, Aniruddh, Menkiszak, Janusz, Lubinski, Jan, Narod, Steven A., Cybulski, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511696/ https://www.ncbi.nlm.nih.gov/pubmed/23099437 http://dx.doi.org/10.1007/s10549-012-2295-y |
Ejemplares similares
-
HOXB13 mutations and prostate cancer in Poland
por: Kluźniak, Wojciech, et al.
Publicado: (2012) -
Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates
por: Cai, Qiliang, et al.
Publicado: (2015) -
NBS1 Mutation and prognosis of prostate cancer
por: Wokołorczyk, Dominika, et al.
Publicado: (2012) -
Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Comparative functional characterization of novel non-syndromic GJB2 gene variant p.Gly45Arg and lethal syndromic variant p.Gly45Glu
por: Rodriguez-Paris, Juan, et al.
Publicado: (2016)